ESMO Immuno-Oncology Congress 2024
- Start date
- 11 Dec 2024
- End date
- 13 Dec 2024
- Location
- Geneva, Switzerland
The ESMO Immuno-Oncology Congress 2024, took place from 11 until 13 December 2024 in Geneva, Switzerland, and online.
This international event provided an advanced educational programme and showcased recent scientific developments in this promising and fast-evolving field.
From the basics of immunotherapies to the latest research results; from understanding different treatment options to the management of toxicities and interpretation of new data, this event catered to the diverse needs of oncology stakeholders with an interest in this topical field of cancer treatment.
ESMO Immuno-Oncology 2024 Scientific Committee Co-Chairs:
Michele Maio “A great opportunity to share our ideas and the results of our research” |
Aurélien Marabelle “An event to access the most recent discoveries in the field” |
Inge Marie Svane “This event gathers key stakeholders, to guarantee that this field moves forward” |
Photo Gallery
Programme
The ESMO Immuno-Oncology 2024 programme is online!
Certificate of Attendance
Please download your certificate from the myESMO area
Abstracts
The abstract submission is now open!
Information for Presenters
Find here instructions to assist with your presentation
Congress Officers
Find out the ESMO Immuno-Oncology Congress 2024 Scientific Co-Chairs and Scientific Committee Experts
Exhibition
Information about the Exhibition
Industry Participation
Industry partners: find out how to get involved
Venue
The ESMO Immuno-Oncology Congress 2024 will take place at the Palexpo exhibition centre in Geneva, Switzerland
Accommodation
Kuoni Global Travel Services Congress has been appointed as official housing agency for the ESMO Immuno-Oncology 2024
Press & Media
Information for media representatives
Social Media
Follow #ESMOImmuno24 on Facebook, X (Twitter), LinkedIn, Instagram and YouTube
Contacts
Get in touch with the organisers of ESMO Immuno-Oncology Congress 2024
Practical Information
Frequently Asked Questions